{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:00:07Z","timestamp":1790269207472,"version":"4.1.0"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02756-w","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:34:09Z","timestamp":1786786449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatially organized regulated cell death-immune coupling in solid tumors: integrating spatial omics with actionable regulated cell death biology"],"prefix":"10.1186","volume":"25","author":[{"given":"Jinkang","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianjie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"issue":"1","key":"2756_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40164-022-00277-y","volume":"11","author":"Q Jia","year":"2022","unstructured":"Jia Q, Wang A, Yuan Y, Zhu B, Long H. Heterogeneity of the tumor immune microenvironment and its clinical relevance. Exp Hematol Oncol. 2022;11(1):24.","journal-title":"Exp Hematol Oncol"},{"issue":"7467","key":"2756_CR2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501(7467):346\u201354.","journal-title":"Nature"},{"issue":"2","key":"2756_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81\u201394.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2756_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"MZ Jin","year":"2020","unstructured":"Jin MZ, Jin WL. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5(1):166.","journal-title":"Signal Transduct Target Ther"},{"key":"2756_CR5","doi-asserted-by":"publisher","unstructured":"Ma A, Xiang L, Yuan J, Wang Q, Zhao L, Yan H. Spatial Transcriptomics Decodes Breast Cancer Microenvironment Heterogeneity: From Multidimensional Dynamic Profiling to Precision Therapy Blueprint Construction. Biomolecules. 2025;15(8):1067. https:\/\/doi.org\/10.3390\/biom15081067.","DOI":"10.3390\/biom15081067"},{"issue":"3","key":"2756_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ccell.2025.01.012","volume":"43","author":"H Chen","year":"2025","unstructured":"Chen H, Deng C, Gao J, Wang J, Fu F, Wang Y, et al. Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer. Cancer Cell. 2025;43(3):519\u201336. e5.","journal-title":"Cancer Cell"},{"issue":"1","key":"2756_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang S, Ma J, Chen Z, Song G, Rao D, et al. Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level. Cancer Discov. 2022;12(1):134\u201353.","journal-title":"Cancer Discov"},{"key":"2756_CR8","doi-asserted-by":"publisher","unstructured":"Tanaka M, Lum L, Hu KH, et al. Tumor cell heterogeneity drives spatial organization of the intratumoral immune response. J Exp Med. 2025;222(6):e20242282. https:\/\/doi.org\/10.1084\/jem.20242282.","DOI":"10.1084\/jem.20242282"},{"issue":"1","key":"2756_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12943-025-02426-3","volume":"24","author":"J Le","year":"2025","unstructured":"Le J, Dian Y, Zhao D, Guo Z, Luo Z, Chen X, et al. Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment. Mol Cancer. 2025;24(1):221.","journal-title":"Mol Cancer"},{"issue":"10","key":"2756_CR10","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/s43018-024-00824-y","volume":"5","author":"X Qiu","year":"2024","unstructured":"Qiu X, Zhou T, Li S, Wu J, Tang J, Ma G, et al. Spatial single-cell protein landscape reveals vimentin(high) macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma. Nat Cancer. 2024;5(10):1557\u201378.","journal-title":"Nat Cancer"},{"issue":"8","key":"2756_CR11","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","volume":"56","author":"A Sattiraju","year":"2023","unstructured":"Sattiraju A, Kang S, Giotti B, Chen Z, Marallano VJ, Brusco C, et al. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression. Immunity. 2023;56(8):1825\u2013e436.","journal-title":"Immunity"},{"issue":"1","key":"2756_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","volume":"14","author":"T Fu","year":"2021","unstructured":"Fu T, Dai LJ, Wu SY, Xiao Y, Ma D, Jiang YZ, et al. Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. J Hematol Oncol. 2021;14(1):98.","journal-title":"J Hematol Oncol"},{"issue":"10","key":"2756_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00262-025-04183-0","volume":"74","author":"C Tan","year":"2025","unstructured":"Tan C, Huang J, Gao N, Wu B, Juliet M, Xiao J, et al. Dynamic remodeling of tertiary lymphoid structures in response to cancer therapy: a recent review. Cancer Immunol Immunother. 2025;74(10):313.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2756_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","volume":"10","author":"T Pu","year":"2025","unstructured":"Pu T, Sun J, Ren G, Li H. Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications. Signal Transduct Target Ther. 2025;10(1):176.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2756_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486\u2013541.","journal-title":"Cell Death Differ"},{"key":"2756_CR16","doi-asserted-by":"publisher","unstructured":"Hu J, Li Y, Lian B, Mao Y, Zhao L. Mechanism and role of regulated cell death in tumor immunity and immunotherapy. Cancer Commun (Lond). 2025;45(11):1456\u201395. https:\/\/doi.org\/10.1002\/cac2.70064.","DOI":"10.1002\/cac2.70064"},{"issue":"1","key":"2756_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7(1):286.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2756_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15(1):174.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2756_CR19","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41575-021-00486-6","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Zeh HJ, Kang R, Kroemer G, Tang D. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol. 2021;18(11):804\u201323.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"2756_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/procel\/pwae003","volume":"15","author":"C Mao","year":"2024","unstructured":"Mao C, Wang M, Zhuang L, Gan B. Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond. Protein Cell. 2024;15(9):642\u201360.","journal-title":"Protein Cell"},{"issue":"1","key":"2756_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12943-025-02491-8","volume":"24","author":"H Zhang","year":"2025","unstructured":"Zhang H, Li S, Liu S, Liao Y, Liu H, Yang M, et al. Therapeutic targeting of cell death-immune crosstalk in cancer to rewire the tumor immune microenvironment. Mol Cancer. 2025;24(1):277.","journal-title":"Mol Cancer"},{"issue":"1","key":"2756_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12943-024-02130-8","volume":"23","author":"X Zhang","year":"2024","unstructured":"Zhang X, Tang B, Luo J, Yang Y, Weng Q, Fang S, et al. Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope. Mol Cancer. 2024;23(1):255.","journal-title":"Mol Cancer"},{"issue":"8","key":"2756_CR23","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Kang R, Klionsky DJ, Tang D, Liu J, Chen X. Copper metabolism in cell death and autophagy. Autophagy. 2023;19(8):2175\u201395.","journal-title":"Autophagy"},{"issue":"3","key":"2756_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M, et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol. 2023;25(3):404\u201314.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"2756_CR25","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/s41416-021-01680-8","volume":"126","author":"B Darvishi","year":"2022","unstructured":"Darvishi B, Eisavand MR, Majidzadeh AK, Farahmand L. Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance. Br J Cancer. 2022;126(9):1253\u201363.","journal-title":"Br J Cancer"},{"issue":"12","key":"2756_CR26","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1111\/jcmm.17395","volume":"26","author":"Y Han","year":"2022","unstructured":"Han Y, Zhang X, Guan M, Huo C, Yu C, Hu B, et al. RASSF4 inhibits cell proliferation and increases drug sensitivity in colorectal cancer through YAP\/Bcl-2 pathway. J Cell Mol Med. 2022;26(12):3538\u201347.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2756_CR27","doi-asserted-by":"publisher","first-page":"100023","DOI":"10.1016\/j.mbm.2023.100023","volume":"1","author":"T Li","year":"2023","unstructured":"Li T, Li Y, Wu H, Peng C, Wang J, Chen S, et al. Extracellular cell matrix stiffness-driven drug resistance of breast cancer cells via EGFR activation. Mechanobiol Med. 2023;1(2):100023.","journal-title":"Mechanobiol Med"},{"key":"2756_CR28","doi-asserted-by":"publisher","unstructured":"Park Y, Lee D, Lee JE, et al. The Matrix Stiffness Coordinates the Cell Proliferation and PD-L1 Expression via YAP in Lung Adenocarcinoma. Cancers (Basel). 2024;16(3):598. https:\/\/doi.org\/10.3390\/cancers16030598.","DOI":"10.3390\/cancers16030598"},{"issue":"2","key":"2756_CR29","doi-asserted-by":"publisher","first-page":"103733","DOI":"10.1016\/j.isci.2022.103733","volume":"25","author":"Y Song","year":"2022","unstructured":"Song Y, Chen J, Zhang C, Xin L, Li Q, Liu Y, et al. Mechanosensitive channel Piezo1 induces cell apoptosis in pancreatic cancer by ultrasound with microbubbles. iScience. 2022;25(2):103733.","journal-title":"iScience"},{"key":"2756_CR30","doi-asserted-by":"publisher","first-page":"1467602","DOI":"10.3389\/fimmu.2024.1467602","volume":"15","author":"X Feng","year":"2024","unstructured":"Feng X, Cao F, Wu X, Xie W, Wang P, Jiang H. Targeting extracellular matrix stiffness for cancer therapy. Front Immunol. 2024;15:1467602.","journal-title":"Front Immunol"},{"issue":"7769","key":"2756_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572(7769):402\u20136.","journal-title":"Nature"},{"issue":"6","key":"2756_CR32","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1158\/1541-7786.MCR-20-0534","volume":"19","author":"WH Yang","year":"2021","unstructured":"Yang WH, Lin CC, Wu J, Chao PY, Chen K, Chen PH, et al. The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2. Mol Cancer Res. 2021;19(6):1005\u201314.","journal-title":"Mol Cancer Res"},{"issue":"6","key":"2756_CR33","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/15548627.2025.2469129","volume":"21","author":"C Luo","year":"2025","unstructured":"Luo C, Liang H, Ji M, Ye C, Lin Y, Guo Y, et al. Autophagy induced by mechanical stress sensitizes cells to ferroptosis by NCOA4-FTH1 axis. Autophagy. 2025;21(6):1263\u201382.","journal-title":"Autophagy"},{"issue":"8","key":"2756_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41422-023-00831-1","volume":"33","author":"L Wu","year":"2023","unstructured":"Wu L, Yan J, Bai Y, Chen F, Zou X, Xu J, et al. An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression. Cell Res. 2023;33(8):585\u2013603.","journal-title":"Cell Res"},{"issue":"1","key":"2756_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43.","journal-title":"Mol Cancer"},{"issue":"4","key":"2756_CR36","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.7150\/thno.89805","volume":"14","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Fang S, Fan B, Xu K, Xu L, Wang L, et al. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer. Theranostics. 2024;14(4):1683\u2013700.","journal-title":"Theranostics"},{"issue":"1","key":"2756_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","volume":"42","author":"P Zheng","year":"2023","unstructured":"Zheng P, Zhou C, Ding Y, Duan S. Disulfidptosis: a new target for metabolic cancer therapy. J Exp Clin Cancer Res. 2023;42(1):103.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"2756_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41419-023-06129-9","volume":"14","author":"V Del Vecchio","year":"2023","unstructured":"Del Vecchio V, Mele L, Panda SK, Sanchez-Pajares IR, Mosca L, Tirino V, et al. beta(2)-AR inhibition enhances EGFR antibody efficacy hampering the oxidative stress response machinery. Cell Death Dis. 2023;14(9):613.","journal-title":"Cell Death Dis"},{"issue":"4","key":"2756_CR39","first-page":"1295","volume":"42","author":"J Deng","year":"2019","unstructured":"Deng J, Jiang P, Yang T, Huang M, Xie J, Luo C, et al. beta2\u2013adrenergic receptor signaling promotes neuroblastoma cell proliferation by activating autophagy. Oncol Rep. 2019;42(4):1295\u2013306.","journal-title":"Oncol Rep"},{"issue":"12","key":"2756_CR40","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1172\/JCI129502","volume":"129","author":"H Mohammadpour","year":"2019","unstructured":"Mohammadpour H, MacDonald CR, Qiao G, Chen M, Dong B, Hylander BL, et al. beta2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest. 2019;129(12):5537\u201352.","journal-title":"J Clin Invest"},{"issue":"7935","key":"2756_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","volume":"611","author":"M Balood","year":"2022","unstructured":"Balood M, Ahmadi M, Eichwald T, Ahmadi A, Majdoubi A, Roversi K, et al. Nociceptor neurons affect cancer immunosurveillance. Nature. 2022;611(7935):405\u201312.","journal-title":"Nature"},{"issue":"8059","key":"2756_CR42","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41586-025-08591-1","volume":"640","author":"X Zhi","year":"2025","unstructured":"Zhi X, Wu F, Qian J, Ochiai Y, Lian G, Malagola E, et al. Nociceptive neurons promote gastric tumour progression via a CGRP-RAMP1 axis. Nature. 2025;640(8059):802\u201310.","journal-title":"Nature"},{"key":"2756_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cancers17152464","volume":"17","author":"R Kishan","year":"2025","unstructured":"Kishan R, Zhang G, Yang W, Su Y. Bioinformatics Screening of Tumor-Derived Neuropeptides Mediating Neuroimmune Axis of Head and Neck Cancer. Cancers (Basel). 2025;17:15.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"2756_CR44","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s41590-023-01678-9","volume":"24","author":"LA Walsh","year":"2023","unstructured":"Walsh LA, Quail DF. Decoding the tumor microenvironment with spatial technologies. Nat Immunol. 2023;24(12):1982\u201393.","journal-title":"Nat Immunol"},{"issue":"11","key":"2756_CR45","doi-asserted-by":"publisher","first-page":"100340","DOI":"10.1016\/j.crmeth.2022.100340","volume":"2","author":"A Lyubetskaya","year":"2022","unstructured":"Lyubetskaya A, Rabe B, Fisher A, Lewin A, Neuhaus I, Brett C, et al. Assessment of spatial transcriptomics for oncology discovery. Cell Rep Methods. 2022;2(11):100340.","journal-title":"Cell Rep Methods"},{"issue":"1","key":"2756_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40478-024-01769-0","volume":"12","author":"M Liu","year":"2024","unstructured":"Liu M, Ji Z, Jain V, Smith VL, Hocke E, Patel AP, et al. Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche. Acta Neuropathol Commun. 2024;12(1):64.","journal-title":"Acta Neuropathol Commun"},{"issue":"15","key":"2756_CR47","doi-asserted-by":"publisher","first-page":"e2204514","DOI":"10.1002\/advs.202204514","volume":"10","author":"CH Chung","year":"2023","unstructured":"Chung CH, Lin CY, Chen CY, Hsueh CW, Chang YW, Wang CC, et al. Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer. Adv Sci (Weinh). 2023;10(15):e2204514.","journal-title":"Adv Sci (Weinh)"},{"key":"2756_CR48","doi-asserted-by":"publisher","first-page":"1589563","DOI":"10.3389\/fimmu.2025.1589563","volume":"16","author":"K Lei","year":"2025","unstructured":"Lei K, Zhao Y, Li S, Liu J, Chen W, Zhou C, et al. Integrative spatial and single-cell transcriptomics elucidate programmed cell death-driven tumor microenvironment dynamics in hepatocellular carcinoma. Front Immunol. 2025;16:1589563.","journal-title":"Front Immunol"},{"key":"2756_CR49","doi-asserted-by":"publisher","first-page":"1693940","DOI":"10.3389\/fimmu.2025.1693940","volume":"16","author":"L Fang","year":"2025","unstructured":"Fang L, Wang D, Meng F, Wang Y, Feng L, Li H. Single-cell and machine learning-based pyroptosis-related gene signature predicts prognosis and immunotherapy response in glioblastoma. Front Immunol. 2025;16:1693940.","journal-title":"Front Immunol"},{"key":"2756_CR50","doi-asserted-by":"publisher","unstructured":"Kisakol B, Sturrock A, Cho S, et al. High-Resolution Spatial Proteomics Characterises Colorectal Cancer Consensus Molecular Subtypes. Preprint. bioRxiv. 2025;2025.05.07.652478. https:\/\/doi.org\/10.1101\/2025.05.07.652478.","DOI":"10.1101\/2025.05.07.652478"},{"key":"2756_CR51","doi-asserted-by":"publisher","unstructured":"Song X, Zhu Y, Geng W, et al. Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. J Immunother Cancer. 2025;13(1):e010183. https:\/\/doi.org\/10.1136\/jitc-2024-010183.","DOI":"10.1136\/jitc-2024-010183"},{"key":"2756_CR52","doi-asserted-by":"publisher","first-page":"1672312","DOI":"10.3389\/fimmu.2025.1672312","volume":"16","author":"A Vallee","year":"2025","unstructured":"Vallee A, Drezet A, Arutkin M. Pan-cancer convergence of tumour-immune microenvironment motifs revealed by CyTOF and imaging mass cytometry. Front Immunol. 2025;16:1672312.","journal-title":"Front Immunol"},{"issue":"12","key":"2756_CR53","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.7150\/thno.108817","volume":"15","author":"J Xu","year":"2025","unstructured":"Xu J, Weng C, Zhang Y, Zhao Q, Chen J, Pan S, et al. GPX4 knockdown suppresses M2 macrophage polarization in gastric cancer by modulating kynurenine metabolism. Theranostics. 2025;15(12):5826\u201345.","journal-title":"Theranostics"},{"key":"2756_CR54","doi-asserted-by":"publisher","first-page":"1458035","DOI":"10.3389\/fimmu.2024.1458035","volume":"15","author":"AO Yam","year":"2024","unstructured":"Yam AO, Jakovija A, Gatt C, Chtanova T. Neutrophils under the microscope: neutrophil dynamics in infection, inflammation, and cancer revealed using intravital imaging. Front Immunol. 2024;15:1458035.","journal-title":"Front Immunol"},{"issue":"1","key":"2756_CR55","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/s41467-023-36560-7","volume":"14","author":"Z Xun","year":"2023","unstructured":"Xun Z, Ding X, Zhang Y, Zhang B, Lai S, Zou D, et al. Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis. Nat Commun. 2023;14(1):933.","journal-title":"Nat Commun"},{"key":"2756_CR56","doi-asserted-by":"publisher","unstructured":"Noorbakhsh J, Foroughi Pour A, Chuang J. Emerging AI approaches for cancer spatial omics. Gigascience. 2025;14:giaf128. https:\/\/doi.org\/10.1093\/gigascience\/giaf128.","DOI":"10.1093\/gigascience\/giaf128"},{"key":"2756_CR57","doi-asserted-by":"publisher","unstructured":"Ge S, Sun S, Xu H, Cheng Q, Ren Z. Deep learning in single-cell and spatial transcriptomics data analysis: advances and challenges from a data science perspective. Brief Bioinform. 2025;26(2):bbaf136. https:\/\/doi.org\/10.1093\/bib\/bbaf136.","DOI":"10.1093\/bib\/bbaf136"},{"issue":"1","key":"2756_CR58","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41467-023-36796-3","volume":"14","author":"Y Long","year":"2023","unstructured":"Long Y, Ang KS, Li M, Chong KLK, Sethi R, Zhong C, et al. Spatially informed clustering, integration, and deconvolution of spatial transcriptomics with GraphST. Nat Commun. 2023;14(1):1155.","journal-title":"Nat Commun"},{"issue":"1","key":"2756_CR59","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1038\/s41467-025-58079-9","volume":"16","author":"S Fang","year":"2025","unstructured":"Fang S, Xu M, Cao L, Liu X, Bezulj M, Tan L, et al. Stereopy: modeling comparative and spatiotemporal cellular heterogeneity via multi-sample spatial transcriptomics. Nat Commun. 2025;16(1):3741.","journal-title":"Nat Commun"},{"issue":"1","key":"2756_CR60","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41467-024-44835-w","volume":"15","author":"Y Liang","year":"2024","unstructured":"Liang Y, Shi G, Cai R, Yuan Y, Xie Z, Yu L, et al. PROST: quantitative identification of spatially variable genes and domain detection in spatial transcriptomics. Nat Commun. 2024;15(1):600.","journal-title":"Nat Commun"},{"issue":"2","key":"2756_CR61","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41592-022-01728-4","volume":"20","author":"Z Cang","year":"2023","unstructured":"Cang Z, Zhao Y, Almet AA, Stabell A, Ramos R, Plikus MV, et al. Screening cell-cell communication in spatial transcriptomics via collective optimal transport. Nat Methods. 2023;20(2):218\u201328.","journal-title":"Nat Methods"},{"issue":"1","key":"2756_CR62","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.1038\/s41467-022-34867-5","volume":"13","author":"Z Yuan","year":"2022","unstructured":"Yuan Z, Li Y, Shi M, Yang F, Gao J, Yao J, et al. SOTIP is a versatile method for microenvironment modeling with spatial omics data. Nat Commun. 2022;13(1):7330.","journal-title":"Nat Commun"},{"issue":"1","key":"2756_CR63","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1038\/s41467-025-61476-9","volume":"16","author":"Y Cui","year":"2025","unstructured":"Cui Y, Yuan Z. Prioritizing perturbation-responsive gene patterns using interpretable deep learning. Nat Commun. 2025;16(1):6095.","journal-title":"Nat Commun"},{"issue":"1","key":"2756_CR64","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-024-01596-9","volume":"17","author":"X Liu","year":"2024","unstructured":"Liu X, Peng T, Xu M, Lin S, Hu B, Chu T, et al. Spatial multi-omics: deciphering technological landscape of integration of multi-omics and its applications. J Hematol Oncol. 2024;17(1):72.","journal-title":"J Hematol Oncol"},{"key":"2756_CR65","doi-asserted-by":"publisher","unstructured":"Abdulrahman Z, Slieker RC, McGuire D, Welters MJP, van Poelgeest MIE, van der Burg SH. Single-cell spatial transcriptomics unravels cell states and ecosystems associated with clinical response to immunotherapy. J Immunother Cancer. 2025;13(3):e011308. https:\/\/doi.org\/10.1136\/jitc-2024-011308.","DOI":"10.1136\/jitc-2024-011308"},{"issue":"7799","key":"2756_CR66","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","volume":"579","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579(7799):415\u201320.","journal-title":"Nature"},{"issue":"1","key":"2756_CR67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12943-025-02506-4","volume":"24","author":"A Alishvandi","year":"2025","unstructured":"Alishvandi A, Aram C, Shahrivar FF, Kesharwani P, Sahebkar A. Pyroptosis in cancer therapy: a double-edged sword for immune activation and tumor progression. Mol Cancer. 2025;24(1):297.","journal-title":"Mol Cancer"},{"key":"2756_CR68","doi-asserted-by":"publisher","unstructured":"Wilski-Cronin NA, Erkes DA, Purwin TJ, et al. Pyroptosis Modulates Multiple Immune Cell Populations in Targeted Therapy-Treated Melanoma. Cancer Immunol Res. 2026;14(3):374\u201386. https:\/\/doi.org\/10.1158\/2326-6066.CIR-25-0444.","DOI":"10.1158\/2326-6066.CIR-25-0444"},{"issue":"7","key":"2756_CR69","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nm.2385","volume":"17","author":"Q Huang","year":"2011","unstructured":"Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med. 2011;17(7):860\u20136.","journal-title":"Nat Med"},{"issue":"4","key":"2756_CR70","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1152\/physrev.00036.2024","volume":"105","author":"GS Kopeina","year":"2025","unstructured":"Kopeina GS, Efimenko AY, Tkachuk VA, Zhivotovsky B. Programmed cell death and tissue regeneration: a link that should be resolved. Physiol Rev. 2025;105(4):2377\u2013412.","journal-title":"Physiol Rev"},{"issue":"6866","key":"2756_CR71","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","volume":"414","author":"A Ohta","year":"2001","unstructured":"Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001;414(6866):916\u201320.","journal-title":"Nature"},{"issue":"5","key":"2756_CR72","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280\u201396.","journal-title":"Nat Rev Clin Oncol"},{"key":"2756_CR73","doi-asserted-by":"publisher","unstructured":"Hu K, Li J, Chen K, et al. Hypoxia-induced USP13 expression drives ferroptosis resistance and tumor immune evasion in hepatocellular carcinoma through the stabilization of ACLY. Cell Death Discov. 2025;12(1):28. https:\/\/doi.org\/10.1038\/s41420-025-02869-z.","DOI":"10.1038\/s41420-025-02869-z"},{"key":"2756_CR74","doi-asserted-by":"publisher","first-page":"1549276","DOI":"10.3389\/fimmu.2025.1549276","volume":"16","author":"S Shi","year":"2025","unstructured":"Shi S, Ou X, Liu C, Wen H, Ke J. Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment. Front Immunol. 2025;16:1549276.","journal-title":"Front Immunol"},{"issue":"1","key":"2756_CR75","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13046-025-03569-3","volume":"44","author":"K Lei","year":"2025","unstructured":"Lei K, Chen J, Deng Y, Peng Y, Zhai X, Ren X, et al. Cracking the code of cancer immunotherapy resistance: emerging roles of pyroptosis and necroptosis. J Exp Clin Cancer Res. 2025;44(1):308.","journal-title":"J Exp Clin Cancer Res"},{"key":"2756_CR76","doi-asserted-by":"publisher","unstructured":"Korbecki J, Bosiacki M, Pilarczyk M, et al. The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target. Cancers (Basel). 2025;17(10):1674. https:\/\/doi.org\/10.3390\/cancers17101674.","DOI":"10.3390\/cancers17101674"},{"issue":"12","key":"2756_CR77","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41590-018-0226-8","volume":"19","author":"T Bohn","year":"2018","unstructured":"Bohn T, Rapp S, Luther N, Klein M, Bruehl TJ, Kojima N, et al. Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages. Nat Immunol. 2018;19(12):1319\u201329.","journal-title":"Nat Immunol"},{"issue":"7","key":"2756_CR78","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020;21(7):736\u201345.","journal-title":"Nat Immunol"},{"key":"2756_CR79","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer E, Pedersen SF. The Acidic Tumor Microenvironment as a Driver of Cancer. Annu Rev Physiol. 2020;82:103\u201326.","journal-title":"Annu Rev Physiol"},{"key":"2756_CR80","doi-asserted-by":"publisher","unstructured":"Rathkey JK, Zhao J, Liu Z, et al. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci Immunol. 2018;3(26):eaat2738. https:\/\/doi.org\/10.1126\/sciimmunol.aat2738.","DOI":"10.1126\/sciimmunol.aat2738"},{"issue":"6511","key":"2756_CR81","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.abb9818","volume":"369","author":"F Humphries","year":"2020","unstructured":"Humphries F, Shmuel-Galia L, Ketelut-Carneiro N, Li S, Wang B, Nemmara VV, et al. Succination inactivates gasdermin D and blocks pyroptosis. Science. 2020;369(6511):1633\u20137.","journal-title":"Science"},{"issue":"7","key":"2756_CR82","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396.","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"2756_CR83","doi-asserted-by":"publisher","first-page":"9459","DOI":"10.7150\/thno.113940","volume":"15","author":"GL Su","year":"2025","unstructured":"Su GL, Zhang MJ, Li H, Sun ZJ. Dissecting Tertiary Lymphoid Structures in Cancer: Maturation, Localization and Density. Theranostics. 2025;15(18):9459\u201385.","journal-title":"Theranostics"},{"issue":"4","key":"2756_CR84","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/gutjnl-2024-332281","volume":"74","author":"Y Tu","year":"2025","unstructured":"Tu Y, Wu H, Zhong C, Liu Y, Xiong Z, Chen S, et al. Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma. Gut. 2025;74(4):613\u201327.","journal-title":"Gut"},{"issue":"1","key":"2756_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7150\/ijbs.83586","volume":"20","author":"W Zhou","year":"2024","unstructured":"Zhou W, Lim A, Edderkaoui M, Osipov A, Wu H, Wang Q, et al. Role of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer. Int J Biol Sci. 2024;20(1):15\u201328.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2756_CR86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhang H, Wang J, Liu Y, Luo T, Hua H. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol. 2022;15(1):34.","journal-title":"J Hematol Oncol"},{"key":"2756_CR87","doi-asserted-by":"publisher","first-page":"1698088","DOI":"10.3389\/fimmu.2025.1698088","volume":"16","author":"J He","year":"2025","unstructured":"He J, Tao J, Zhou Y, Li H, Feng W, Xu Y. TGF-beta-driven T-cell exclusion in ovarian cancer: single-cell and spatial transcriptomic views of immune low-response states. Front Immunol. 2025;16:1698088.","journal-title":"Front Immunol"},{"key":"2756_CR88","doi-asserted-by":"publisher","first-page":"1449291","DOI":"10.3389\/fimmu.2024.1449291","volume":"15","author":"PJ Lei","year":"2024","unstructured":"Lei PJ, Fraser C, Jones D, Ubellacker JM, Padera TP. Lymphatic system regulation of anti-cancer immunity and metastasis. Front Immunol. 2024;15:1449291.","journal-title":"Front Immunol"},{"issue":"9","key":"2756_CR89","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553\u201365.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2756_CR90","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader JE, Voss K, Rathmell JC. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy. Mol Cell. 2020;78(6):1019\u201333.","journal-title":"Mol Cell"},{"key":"2756_CR91","doi-asserted-by":"publisher","first-page":"10555","DOI":"10.1038\/ncomms10555","volume":"7","author":"M Karmakar","year":"2016","unstructured":"Karmakar M, Katsnelson MA, Dubyak GR, Pearlman E. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1beta secretion in response to ATP. Nat Commun. 2016;7:10555.","journal-title":"Nat Commun"},{"issue":"7","key":"2756_CR92","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1172\/JCI0215337","volume":"110","author":"K Synnestvedt","year":"2002","unstructured":"Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, et al. Ecto-5\u2019-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest. 2002;110(7):993\u20131002.","journal-title":"J Clin Invest"},{"issue":"11","key":"2756_CR93","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1084\/jem.20050177","volume":"202","author":"HK Eltzschig","year":"2005","unstructured":"Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schonfeld C, et al. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med. 2005;202(11):1493\u2013505.","journal-title":"J Exp Med"},{"key":"2756_CR94","doi-asserted-by":"publisher","first-page":"1677089","DOI":"10.3389\/fimmu.2025.1677089","volume":"16","author":"J Meng","year":"2025","unstructured":"Meng J, Liang C, Li L, Huang Q, Huang W, Wang R, et al. A lactylation-ferroptosis cross-talk gene signature predicts hepatocellular carcinoma prognosis and reveals STMN1\/PRDX1 as therapeutic targets. Front Immunol. 2025;16:1677089.","journal-title":"Front Immunol"},{"issue":"7779","key":"2756_CR95","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"issue":"1","key":"2756_CR96","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1038\/s41467-018-04804-6","volume":"9","author":"H Guak","year":"2018","unstructured":"Guak H, Al Habyan S, Ma EH, Aldossary H, Al-Masri M, Won SY, et al. Glycolytic metabolism is essential for CCR7 oligomerization and dendritic cell migration. Nat Commun. 2018;9(1):2463.","journal-title":"Nat Commun"},{"issue":"7858","key":"2756_CR97","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","volume":"593","author":"BI Reinfeld","year":"2021","unstructured":"Reinfeld BI, Madden MZ, Wolf MM, Chytil A, Bader JE, Patterson AR, et al. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature. 2021;593(7858):282\u20138.","journal-title":"Nature"},{"issue":"23","key":"2756_CR98","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1158\/0008-5472.CAN-24-2038","volume":"85","author":"Y Lu","year":"2025","unstructured":"Lu Y, Yurkevicz AM, Liu Y, Glazer PM. Hypoxia Induces Immunosuppression by Silencing STING in Cancer. Cancer Res. 2025;85(23):4664\u201380.","journal-title":"Cancer Res"},{"issue":"11","key":"2756_CR99","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4(11):891\u20139.","journal-title":"Nat Rev Cancer"},{"key":"2756_CR100","doi-asserted-by":"publisher","first-page":"1554114","DOI":"10.3389\/fimmu.2025.1554114","volume":"16","author":"CR Larson","year":"2025","unstructured":"Larson CR, Mandloi A, Acharyya S, Carstens JL. The tumor microenvironment across four dimensions: assessing space and time in cancer biology. Front Immunol. 2025;16:1554114.","journal-title":"Front Immunol"},{"issue":"11","key":"2756_CR101","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020;21(11):678\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"2756_CR102","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1084\/jem.20101157","volume":"207","author":"KS Ravichandran","year":"2010","unstructured":"Ravichandran KS. Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J Exp Med. 2010;207(9):1807\u201317.","journal-title":"J Exp Med"},{"issue":"6","key":"2756_CR103","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/cdd.2016.13","volume":"23","author":"CB Medina","year":"2016","unstructured":"Medina CB, Ravichandran KS. Do not let death do us part: \u2018find-me\u2019 signals in communication between dying cells and the phagocytes. Cell Death Differ. 2016;23(6):979\u201389.","journal-title":"Cell Death Differ"},{"issue":"63","key":"2756_CR104","doi-asserted-by":"publisher","first-page":"63ra94","DOI":"10.1126\/scitranslmed.3001375","volume":"2","author":"MP Chao","year":"2010","unstructured":"Chao MP, Jaiswal S, Weissman-Tsukamoto R, Alizadeh AA, Gentles AJ, Volkmer J, et al. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med. 2010;2(63):63ra94.","journal-title":"Sci Transl Med"},{"key":"2756_CR105","doi-asserted-by":"publisher","first-page":"1699237","DOI":"10.3389\/fimmu.2025.1699237","volume":"16","author":"N van Buuren","year":"2025","unstructured":"van Buuren N, Xu M, Zhang Y, Correa P, Zaboli S, Madjidi A, et al. CD47 expression in solid tumors correlates with phagocytic tumor-associated macrophage gene signature. Front Immunol. 2025;16:1699237.","journal-title":"Front Immunol"},{"issue":"3","key":"2756_CR106","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s44318-024-00319-7","volume":"44","author":"H Estephan","year":"2025","unstructured":"Estephan H, Tailor A, Parker R, Kreamer M, Papandreou I, Campo L, et al. Hypoxia promotes tumor immune evasion by suppressing MHC-I expression and antigen presentation. EMBO J. 2025;44(3):903\u201322.","journal-title":"EMBO J"},{"issue":"7769","key":"2756_CR107","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019;572(7769):392\u20136.","journal-title":"Nature"},{"issue":"2","key":"2756_CR108","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26(2):225\u201339.","journal-title":"Cancer Metastasis Rev"},{"key":"2756_CR109","doi-asserted-by":"publisher","first-page":"1672601","DOI":"10.3389\/fimmu.2025.1672601","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang J, Han W, Zhang M, Yi Y, Long M. Targeting tumor microenvironmental barriers to enhance immunogenic cell death in solid tumors. Front Immunol. 2025;16:1672601.","journal-title":"Front Immunol"},{"issue":"43","key":"2756_CR110","doi-asserted-by":"publisher","first-page":"17561","DOI":"10.1073\/pnas.1215397109","volume":"109","author":"Y Huang","year":"2012","unstructured":"Huang Y, Yuan J, Righi E, Kamoun WS, Ancukiewicz M, Nezivar J, et al. Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proc Natl Acad Sci U S A. 2012;109(43):17561\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5706","key":"2756_CR111","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307(5706):58\u201362.","journal-title":"Science"},{"key":"2756_CR112","doi-asserted-by":"publisher","first-page":"1446486","DOI":"10.3389\/fphar.2024.1446486","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, He H, Qu L, Shen Q, Dai Y. Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis. Front Pharmacol. 2024;15:1446486.","journal-title":"Front Pharmacol"},{"issue":"5","key":"2756_CR113","doi-asserted-by":"publisher","first-page":"11055","DOI":"10.3390\/ijms160511055","volume":"16","author":"CR Justus","year":"2015","unstructured":"Justus CR, Sanderlin EJ, Yang LV. Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment. Int J Mol Sci. 2015;16(5):11055\u201386.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2756_CR114","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0092-8674(01)00495-0","volume":"106","author":"JS Stamler","year":"2001","unstructured":"Stamler JS, Lamas S, Fang FC. Nitrosylation. the prototypic redox-based signaling mechanism. Cell. 2001;106(6):675\u201383.","journal-title":"Cell"},{"key":"2756_CR115","doi-asserted-by":"publisher","first-page":"1562167","DOI":"10.3389\/fphar.2025.1562167","volume":"16","author":"Q Ye","year":"2025","unstructured":"Ye Q, Zhuang XZ, Li J, Zhou X. Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers. Front Pharmacol. 2025;16:1562167.","journal-title":"Front Pharmacol"},{"issue":"27","key":"2756_CR116","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.2174\/0109298673283734240206020150","volume":"32","author":"JT Zhao","year":"2025","unstructured":"Zhao JT, Zheng X, Rao GW, Zheng Q. Research Progress in the Small Molecule Smac Mimetics in Combination Therapy of Cancer. Curr Med Chem. 2025;32(27):5676\u201393.","journal-title":"Curr Med Chem"},{"issue":"5","key":"2756_CR117","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-024-01281-x","volume":"31","author":"HT Tran","year":"2024","unstructured":"Tran HT, Kratina T, Coutansais A, Michalek D, Hogan BM, Lawlor KE, et al. RIPK3 cleavage is dispensable for necroptosis inhibition but restricts NLRP3 inflammasome activation. Cell Death Differ. 2024;31(5):662\u201371.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2756_CR118","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","volume":"184","author":"R Karki","year":"2021","unstructured":"Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes. Cell. 2021;184(1):149\u201368. e17.","journal-title":"Cell"},{"issue":"9","key":"2756_CR119","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41423-025-01329-z","volume":"22","author":"JF Lin","year":"2025","unstructured":"Lin JF, Wang TT, Huang RZ, Tan YT, Chen DL, Ju HQ. PANoptosis in cancer: bridging molecular mechanisms to therapeutic innovations. Cell Mol Immunol. 2025;22(9):996\u20131011.","journal-title":"Cell Mol Immunol"},{"key":"2756_CR120","doi-asserted-by":"publisher","first-page":"1550800","DOI":"10.3389\/fimmu.2025.1550800","volume":"16","author":"W Ma","year":"2025","unstructured":"Ma W, Wang Q, Guo L, Ju X. The molecular mechanisms, roles, and potential applications of PANoptosis in cancer treatment. Front Immunol. 2025;16:1550800.","journal-title":"Front Immunol"},{"issue":"7","key":"2756_CR121","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1021\/acs.nanolett.3c05039","volume":"24","author":"J Tang","year":"2024","unstructured":"Tang J, Zhu J, Xie H, Song L, Xu G, Li W, et al. Mitochondria-Specific Molecular Crosstalk between Ferroptosis and Apoptosis Revealed by In Situ Raman Spectroscopy. Nano Lett. 2024;24(7):2384\u201391.","journal-title":"Nano Lett"},{"issue":"8","key":"2756_CR122","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ 3, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12(8):1425\u20138.","journal-title":"Autophagy"},{"key":"2756_CR123","doi-asserted-by":"publisher","first-page":"114450","DOI":"10.1016\/j.jconrel.2025.114450","volume":"389","author":"Z Song","year":"2026","unstructured":"Song Z, Gao Y, Zou X, Wang Z, Zhang S, Shen J, et al. Inducing potent ferroptosis in cancer cells by manipulation of ferritinophagy with a ferritin-targeted ATTEC. J Control Release. 2026;389:114450.","journal-title":"J Control Release"},{"key":"2756_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20517\/cdr.2024.151","volume":"8","author":"Y Yang","year":"2025","unstructured":"Yang Y, Yu S, Liu W, Zhuo Y, Qu C, Zeng Y. Ferroptosis-related signaling pathways in cancer drug resistance. Cancer Drug Resist. 2025;8:1.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"2756_CR125","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41698-024-00570-5","volume":"8","author":"W Zhang","year":"2024","unstructured":"Zhang W, Zhu Y, Liu H, Zhang Y, Liu H, Adegboro AA, et al. Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response. NPJ Precis Oncol. 2024;8(1):77.","journal-title":"NPJ Precis Oncol"},{"issue":"9","key":"2756_CR126","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00262-024-03752-z","volume":"73","author":"C Fu","year":"2024","unstructured":"Fu C, Ji W, Cui Q, Chen A, Weng H, Lu N, et al. GSDME-mediated pyroptosis promotes anti-tumor immunity of neoadjuvant chemotherapy in breast cancer. Cancer Immunol Immunother. 2024;73(9):177.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"2756_CR127","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3892\/ol.2025.14948","volume":"29","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhang D, Li J, Sun Y, Wang J, Xi L. SNS\u2013032 combined with decitabine induces caspase\u20133\/gasdermin E\u2013dependent pyroptosis in breast cancer cells. Oncol Lett. 2025;29(4):202.","journal-title":"Oncol Lett"},{"key":"2756_CR128","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/ijms25137459","volume":"25","author":"A Hassan","year":"2024","unstructured":"Hassan A, Zhao Y, Chen X, He C. Blockage of Autophagy for Cancer Therapy: A Comprehensive Review. Int J Mol Sci. 2024;25:13.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2756_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.70045","volume":"177","author":"S Ahuja","year":"2026","unstructured":"Ahuja S, Zaheer S. Molecular Mediators of Metabolic Reprogramming in Cancer: Mechanisms, Regulatory Networks, and Therapeutic Strategies. Immunology. 2026;177(1):1\u201343.","journal-title":"Immunology"},{"issue":"4","key":"2756_CR130","doi-asserted-by":"publisher","first-page":"630","DOI":"10.20892\/j.issn.2095-3941.2019.0158","volume":"16","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Shen Y, Chen C, Sui X, Yang J, Wang L, et al. The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer? Cancer Biol Med. 2019;16(4):630\u201346.","journal-title":"Cancer Biol Med"},{"key":"2756_CR131","doi-asserted-by":"publisher","unstructured":"Lee J, Seo Y, Roh JL. Ferroptosis and Nrf2 Signaling in Head and Neck Cancer: Resistance Mechanisms and Therapeutic Prospects. Antioxidants (Basel). 2025;14(8):993. https:\/\/doi.org\/10.3390\/antiox14080993.","DOI":"10.3390\/antiox14080993"},{"key":"2756_CR132","doi-asserted-by":"publisher","first-page":"1611299","DOI":"10.3389\/fimmu.2025.1611299","volume":"16","author":"T Zhang","year":"2025","unstructured":"Zhang T, Gu F, Lin W, Shao H, Jiang A, Guan X. Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade. Front Immunol. 2025;16:1611299.","journal-title":"Front Immunol"},{"issue":"10","key":"2756_CR133","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/s41588-025-02351-7","volume":"57","author":"TN Aung","year":"2025","unstructured":"Aung TN, Monkman J, Warrell J, Vathiotis I, Bates KM, Gavrielatou N, et al. Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer. Nat Genet. 2025;57(10):2482\u201393.","journal-title":"Nat Genet"},{"key":"2756_CR134","doi-asserted-by":"publisher","first-page":"1664726","DOI":"10.3389\/fimmu.2025.1664726","volume":"16","author":"G Liu","year":"2025","unstructured":"Liu G, Zhang X, He Y, Liang D, Xie S, Zhang N, et al. AI-based non-invasive profiling of the tumor immune microenvironment using longitudinal CT radiomics predicts immunotherapy response in lung cancer. Front Immunol. 2025;16:1664726.","journal-title":"Front Immunol"},{"issue":"11","key":"2756_CR135","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00262-025-04192-z","volume":"74","author":"F Xu","year":"2025","unstructured":"Xu F, Kang S, Xu S. Integrating necroptosis and immune landscapes: a multi-omics-derived NecropImmScore stratifies prognosis and therapy in ovarian cancer. Cancer Immunol Immunother. 2025;74(11):340.","journal-title":"Cancer Immunol Immunother"},{"key":"2756_CR136","doi-asserted-by":"publisher","unstructured":"Zheng M, Kessler M, Jeschke U, et al. Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer. Cancers (Basel). 2025;17(2):271. https:\/\/doi.org\/10.3390\/cancers17020271.","DOI":"10.3390\/cancers17020271"},{"key":"2756_CR137","doi-asserted-by":"publisher","unstructured":"Mi H, Sivagnanam S, Ho WJ, et al. Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncology. Brief Bioinform. 2024;25(5):bbae421. https:\/\/doi.org\/10.1093\/bib\/bbae421.","DOI":"10.1093\/bib\/bbae421"},{"issue":"1","key":"2756_CR138","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13059-024-03421-5","volume":"25","author":"Y Wu","year":"2024","unstructured":"Wu Y, Zhou JY, Yao B, Cui G, Zhao YL, Gao CC, et al. STASCAN deciphers fine-resolution cell distribution maps in spatial transcriptomics by deep learning. Genome Biol. 2024;25(1):278.","journal-title":"Genome Biol"},{"key":"2756_CR139","doi-asserted-by":"crossref","unstructured":"Luo GF, Chen WH, Zhang XZ. Nanomedicine Disrupts Stromal Barriers to Augment Drug Penetration for Improved Cancer Therapy\u2020. Chin J Chem. 2024;42(10):1175\u201389.","DOI":"10.1002\/cjoc.202300642"},{"issue":"1","key":"2756_CR140","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","volume":"24","author":"H Sabit","year":"2025","unstructured":"Sabit H, Pawlik TM, Radwan F, Abdel-Hakeem M, Abdel-Ghany S, Wadan AS, et al. Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery. Mol Cancer. 2025;24(1):160.","journal-title":"Mol Cancer"},{"issue":"4","key":"2756_CR141","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.drudis.2021.11.015","volume":"27","author":"Y Fu","year":"2022","unstructured":"Fu Y, Saraswat AL, Monpara J, Patel K. Stromal disruption facilitating invasion of a \u2018nano-arsenal\u2019 into the solid tumor. Drug Discov Today. 2022;27(4):1132\u201341.","journal-title":"Drug Discov Today"},{"key":"2756_CR142","doi-asserted-by":"publisher","first-page":"152590","DOI":"10.1016\/j.cej.2024.152590","volume":"493","author":"L Tang","year":"2024","unstructured":"Tang L, Yin Y, Zhang Z, Fu C, Cao Y, Liu H, et al. Size-switchable and dual-targeting nanomedicine for cancer chemoimmunotherapy by potentiating deep tumor penetration and antitumor immunity. Chem Eng J. 2024;493:152590.","journal-title":"Chem Eng J"},{"issue":"1","key":"2756_CR143","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1021\/acsami.2c18184","volume":"15","author":"Y He","year":"2023","unstructured":"He Y, Tian X, Fan X, Gong X, Tan S, Pan A, et al. Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy. ACS Appl Mater Interfaces. 2023;15(1):552\u201365.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2756_CR144","doi-asserted-by":"publisher","first-page":"122910","DOI":"10.1016\/j.biomaterials.2024.122910","volume":"315","author":"QS Tong","year":"2025","unstructured":"Tong QS, Huang H, Yu HH, Liu R, Shen S, Du JZ. A size-switchable nanocluster remodels the immunosuppressive microenvironment of tumor and tumor-draining lymph nodes for improved cancer immunotherapy. Biomaterials. 2025;315:122910.","journal-title":"Biomaterials"},{"key":"2756_CR145","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jconrel.2024.09.031","volume":"375","author":"E Nekoueifard","year":"2024","unstructured":"Nekoueifard E, Radmanesh F, Zarkesh I, Ebrahimi M, Raoufi M, Abandansari HS, et al. Switchable PAMAM megamers for deep tumor penetration and enhanced cell uptake. J Control Release. 2024;375:478\u201394.","journal-title":"J Control Release"},{"key":"2756_CR146","doi-asserted-by":"publisher","unstructured":"Su MC, Nethi SK, Dhanyamraju PK, Prabha S. Nanomedicine Strategies for Targeting Tumor Stroma. Cancers (Basel). 2023;15(16):4145. https:\/\/doi.org\/10.3390\/cancers15164145.","DOI":"10.3390\/cancers15164145"},{"issue":"1","key":"2756_CR147","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12967-026-07697-y","volume":"24","author":"X Li","year":"2026","unstructured":"Li X, Xue H, Liu Q, Ren L, Sun Y. Triple-remodeling of tumor microenvironment through hyaluronidase-assisted folate-targeted lipid nanoparticle-mediated siVEGF\/siPD-L1 for enhanced tumor immunotherapy. J Transl Med. 2026;24(1):51.","journal-title":"J Transl Med"},{"issue":"Pt 1","key":"2756_CR148","first-page":"149868","volume":"339","author":"D Zhao","year":"2025","unstructured":"Zhao D, Liu Y, Liu Z, Guo X, Zhang L, Zhang H, et al. Hyaluronidase optimizes TACE in hepatocellular carcinoma by remodeling tumor stroma and enhancing chemotherapy penetration. Int J Biol Macromol. 2025;339(Pt 1):149868.","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"2756_CR149","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1021\/acsnano.4c13753","volume":"19","author":"T Jiang","year":"2025","unstructured":"Jiang T, Jia T, Yin Y, Li T, Song X, Feng W, et al. Cuproptosis-Inducing Functional Nanocomposites for Enhanced and Synergistic Cancer Radiotherapy. ACS Nano. 2025;19(5):5429\u201346.","journal-title":"ACS Nano"},{"key":"2756_CR150","first-page":"559","volume":"56","author":"Z Sun","year":"2026","unstructured":"Sun Z, Liu L, Sun J, Xu Y, Zhen M, Wang C, et al. Inducing pyroptosis and reprogramming macrophage via zeolitic imidazolate framework encapsulated-fullerene for two-pronged tumor immunotherapy. Bioact Mater. 2026;56:559\u201370.","journal-title":"Bioact Mater"},{"issue":"46","key":"2756_CR151","doi-asserted-by":"publisher","first-page":"40046","DOI":"10.1021\/acsnano.5c14796","volume":"19","author":"H Nie","year":"2025","unstructured":"Nie H, Gao W, Lv W, Li H, Jiang G, Lin C, et al. Pyroptosis-Inducing Nanoplatform with Plasmonic-Enhanced Phototherapy for Metastasis-Suppressive Cancer Immunotherapy. ACS Nano. 2025;19(46):40046\u201360.","journal-title":"ACS Nano"},{"issue":"17","key":"2756_CR152","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.7150\/thno.115275","volume":"15","author":"K Yun","year":"2025","unstructured":"Yun K, Yu X, Liang S, Wang Q, Zhang Z, Han Y, et al. Tumor-responsive cuproptosis nanoinducer realizing efficient PANoptosis for enhanced cancer immunotherapy. Theranostics. 2025;15(17):9294\u2013305.","journal-title":"Theranostics"},{"issue":"1","key":"2756_CR153","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12951-025-03789-x","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu Y, Hu B, Sun X, Wang J, Deng Z, et al. Hollow spiky MnOx nanocarriers amplify radiotherapy-induced pyroptosis for eliciting antitumor immunity. J Nanobiotechnol. 2025;24(1):19.","journal-title":"J Nanobiotechnol"},{"issue":"9","key":"2756_CR154","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1021\/polymscitech.5c00119","volume":"1","author":"B Zhou","year":"2025","unstructured":"Zhou B, Chen B, Wang Y. Engineering Pyroptosis with Organelle-Targeted Polymeric Materials: Toward Precise Cancer Immunotherapy. Polym Sci Technol. 2025;1(9):745\u20137.","journal-title":"Polym Sci Technol"},{"issue":"3","key":"2756_CR155","doi-asserted-by":"publisher","first-page":"99","DOI":"10.33696\/cancerimmunol.7.109","volume":"7","author":"KA Stanley","year":"2025","unstructured":"Stanley KA, Holmen SL. Targeting FAK to Potentiate Immune Checkpoint Therapy in Solid Tumors. J Cancer Immunol (Wilmington). 2025;7(3):99\u2013108.","journal-title":"J Cancer Immunol (Wilmington)"},{"issue":"17","key":"2756_CR156","doi-asserted-by":"publisher","first-page":"e70790","DOI":"10.1111\/jcmm.70790","volume":"29","author":"M Shayanmanesh","year":"2025","unstructured":"Shayanmanesh M, Ahmadi SE, Amini A. Ferroptosis in Haematological Malignancies: From Regulatory Networks to Novel Therapeutic Opportunities. J Cell Mol Med. 2025;29(17):e70790.","journal-title":"J Cell Mol Med"},{"key":"2756_CR157","doi-asserted-by":"publisher","unstructured":"Caforio M, Iacovelli S, Locatelli F, Folgiero V. Inducing ferroptosis to improve cancer therapy: a promising tool for enhancing immunotherapy. J Exp Clin Cancer Res. 2025;45(1):10. https:\/\/doi.org\/10.1186\/s13046-025-03593-3.","DOI":"10.1186\/s13046-025-03593-3"},{"key":"2756_CR158","doi-asserted-by":"publisher","first-page":"103796","DOI":"10.1016\/j.redox.2025.103796","volume":"86","author":"J Zhu","year":"2025","unstructured":"Zhu J, Li X, Chen W, Zuo Z, Gong Q, Hu J, et al. Ferroptosis triggers anti-tumor immunity via promoting chaperone-mediated autophagic degradation of SHP2. Redox Biol. 2025;86:103796.","journal-title":"Redox Biol"},{"key":"2756_CR159","doi-asserted-by":"publisher","first-page":"1438807","DOI":"10.3389\/fimmu.2024.1438807","volume":"15","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Sun M. SLC7A11: the Achilles heel of tumor? Front Immunol. 2024;15:1438807.","journal-title":"Front Immunol"},{"issue":"21","key":"2756_CR160","doi-asserted-by":"publisher","first-page":"22055","DOI":"10.1021\/acs.jmedchem.5c02094","volume":"68","author":"S Liu","year":"2025","unstructured":"Liu S, Zhang M, Sun X, Wang P, Zhang G, Li W. Application of Hypoxia-Activated Prodrugs in Tumor Therapy: Design Strategies and Perspectives. J Med Chem. 2025;68(21):22055\u201394.","journal-title":"J Med Chem"},{"issue":"9","key":"2756_CR161","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054\u201381.","journal-title":"Autophagy"},{"issue":"7","key":"2756_CR162","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","volume":"29","author":"H Wang","year":"2021","unstructured":"Wang H, Cheng Y, Mao C, Liu S, Xiao D, Huang J, et al. Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol Ther. 2021;29(7):2185\u2013208.","journal-title":"Mol Ther"},{"issue":"1","key":"2756_CR163","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6(1):128.","journal-title":"Signal Transduct Target Ther"},{"issue":"17","key":"2756_CR164","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1016\/j.cell.2024.07.040","volume":"187","author":"L Liu","year":"2024","unstructured":"Liu L, Chen A, Li Y, Mulder J, Heyn H, Xu X. Spatiotemporal omics for biology and medicine. Cell. 2024;187(17):4488\u2013519.","journal-title":"Cell"},{"issue":"26","key":"2756_CR165","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.1016\/j.cell.2024.10.011","volume":"187","author":"X Qiu","year":"2024","unstructured":"Qiu X, Zhu DY, Lu Y, Yao J, Jing Z, Min KH, et al. Spatiotemporal modeling of molecular holograms. Cell. 2024;187(26):7351\u2013e7361.","journal-title":"Cell"},{"key":"2756_CR166","doi-asserted-by":"publisher","unstructured":"Zahedi R, Ghamsari R, Argha A, et al. Deep learning in spatially resolved transcriptfomics: a comprehensive technical view. Brief Bioinform. 2024;25(2):bbae082. https:\/\/doi.org\/10.1093\/bib\/bbae082.","DOI":"10.1093\/bib\/bbae082"},{"key":"2756_CR167","doi-asserted-by":"publisher","unstructured":"Grzeski M, Jensen PM, Hempel BF, et al. Integrating MALDI-MSI-Based Spatial Proteomics and Machine Learning to Predict Chemoradiotherapy Outcomes in Head and Neck Cancer. Int J Mol Sci. 2025;26(18):9084. https:\/\/doi.org\/10.3390\/ijms26189084.","DOI":"10.3390\/ijms26189084"},{"issue":"7","key":"2756_CR168","doi-asserted-by":"publisher","first-page":"433","DOI":"10.14348\/molcells.2021.0042","volume":"44","author":"YJ Heo","year":"2021","unstructured":"Heo YJ, Hwa C, Lee GH, Park JM, An JY. Integrative Multi-Omics Approaches in Cancer Research: From Biological Networks to Clinical Subtypes. Mol Cells. 2021;44(7):433\u201343.","journal-title":"Mol Cells"},{"key":"2756_CR169","doi-asserted-by":"crossref","unstructured":"Huang S, Ouyang L, Tang J, Qian K, Chen X, Xu Z, et al. Spatial transcriptomics: a new frontier in cancer research. Clin Cancer Bull. 2024;3(1).","DOI":"10.1007\/s44272-024-00018-8"},{"issue":"1","key":"2756_CR170","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41467-025-56276-0","volume":"16","author":"Y Yang","year":"2025","unstructured":"Yang Y, Cui Y, Zeng X, Zhang Y, Loza M, Park SJ, et al. STAIG: Spatial transcriptomics analysis via image-aided graph contrastive learning for domain exploration and alignment-free integration. Nat Commun. 2025;16(1):1067.","journal-title":"Nat Commun"},{"issue":"8","key":"2756_CR171","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/s41592-024-02363-x","volume":"21","author":"K Coleman","year":"2024","unstructured":"Coleman K, Schroeder A, Li M. Unlocking the power of spatial omics with AI. Nat Methods. 2024;21(8):1378\u201381.","journal-title":"Nat Methods"},{"issue":"4","key":"2756_CR172","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10555-025-10304-z","volume":"44","author":"JE See","year":"2025","unstructured":"See JE, Barlow S, Arjumand W, DuBose H, Segato Dezem F, Plummer J. Spatial omics: applications and utility in profiling the tumor microenvironment. Cancer Metastasis Rev. 2025;44(4):87.","journal-title":"Cancer Metastasis Rev"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02756-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02756-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02756-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:03:27Z","timestamp":1790265807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02756-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":172,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2756"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02756-w","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the content, and agree to publish.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"226"}}